RAF around the Edges - The Paradox of BRAF Inhibitors

被引：35
|
作者：
Weeraratna, Ashani T. [1 ]
机构：
[1] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 03期
关键词：
RESISTANCE; MELANOMA;
D O I：
10.1056/NEJMe1111636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：271 / 273
页数：3
相关论文
共 50 条
  • [41] Resistance to RAF Inhibition in BRAF Mutant Colorectal Cancer
    Corcoran, Ryan B.
    ONCOLOGIST, 2012, 17 : 2 - 2
  • [42] TARGETING RAF KINASES IN BRAF AND KRAS MUTANT CANCERS
    Luo, J.
    ANNALS OF ONCOLOGY, 2013, 24 : 15 - 15
  • [43] BRAF Inhibitors and Melanoma
    Flaherty, Keith T.
    CANCER JOURNAL, 2011, 17 (06): : 505 - 511
  • [44] TEAMWORK - ROUGH AROUND THE EDGES
    OMAN, P
    PERRONE, G
    MOREAUX, D
    IEEE SOFTWARE, 1990, 7 (02) : 106 - 108
  • [45] PHILADELPHIA - ROUGH AROUND THE EDGES
    DIAMOND, D
    COLUMBIA JOURNALISM REVIEW, 1982, 21 (01) : 15 - 15
  • [46] Resistance to RAF Inhibitors Due to RAS-independent Dimerization of BRAF(V600E) Splicing Variants
    Poulikakos, P. I.
    Persaud, Y.
    Janakiraman, M.
    Gabay, M. T.
    Dahlman, K. B.
    Sosman, J. A.
    Ribas, A.
    Lo, R. S.
    Rosen, N.
    Solit, D. B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 49 - 50
  • [47] Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling
    Adamopoulos, Christos
    Ahmed, Tamer A.
    Tucker, Maxwell R.
    Ung, Peter M. U.
    Xiao, Min
    Karoulia, Zoi
    Amabile, Angelo
    Wu, Xuewei
    Aaronson, Stuart A.
    Ang, Celina
    Rebecca, Vito W.
    Brown, Brian D.
    Schlessinger, Avner
    Herlyn, Meenhard
    Wang, Qi
    Shaw, David E.
    Poulikakos, Poulikos, I
    CANCER DISCOVERY, 2021, 11 (07) : 1716 - 1735
  • [48] RAS-independent dimerization of BRAF(V600E) splicing variants promotes resistance to RAF inhibitors
    Poulikakos, Poulikos I.
    Persaud, Yogindra
    Janakiraman, Manickam
    Kong, Xiangju
    Ng, Charles
    Moriceau, Gatien
    Shi, Hubing
    Atefi, Mohammad
    Titz, Bjoern
    Gabay, May Tal
    Salton, Maayan
    Dahlman, Kimberly B.
    Tadi, Madhavi
    Wargo, Jennifer A.
    Flaherty, Keith T.
    Kelley, Mark C.
    Misteli, Tom
    Chapman, Paul B.
    Sosman, Jeffrey A.
    Graeber, Thomas G.
    Ribas, Antoni
    Lo, Roger S.
    Rosen, Neal
    Solit, David B.
    CANCER RESEARCH, 2012, 72
  • [49] Structural Investigation of B-Raf Paradox Breaker and Inducer Inhibitors (vol 58, pg 1818, 2015)
    Arora, Rohit
    Di Michele, Michela
    Stes, Elisabeth
    Vandermarliere, Elien
    Martens, Lennart
    Gevaert, Kris
    Van Heerde, Erika
    Linders, Joannes T. M.
    Brehmer, Dirk
    Jacoby, Edgar
    Bonnet, Pascal
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (14) : 6973 - 6973
  • [50] Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo
    Ouyang, B
    Knauf, JA
    Smith, EP
    Zhang, L
    Ramsey, T
    Yusuff, N
    Batt, D
    Fagin, JA
    CLINICAL CANCER RESEARCH, 2006, 12 (06) : 1785 - 1793
12345